These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 28872489)

  • 1. A case of pure red cell aplasia during nivolumab therapy for cardiac metastatic melanoma.
    Yuki A; Takenouchi T; Takatsuka S; Ishiguro T
    Melanoma Res; 2017 Dec; 27(6):635-637. PubMed ID: 28872489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Case of Suspected Pure Red Cell Aplasia Due to Nivolumab Treatment for Unresectable Esophageal Cancer].
    Ogawa R; Suzuki K; Saito K; Shinohara H; Atsuta Y; Miura A
    Gan To Kagaku Ryoho; 2023 Dec; 50(13):1786-1788. PubMed ID: 38303207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and management of pure red cell aplasia].
    Hirokawa M
    Rinsho Ketsueki; 2015 Oct; 56(10):1922-31. PubMed ID: 26458430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Checkpoint Inhibitor-Induced Pure Red Cell Aplasia: A Review of 2 Cases in Metastatic Melanoma.
    Rueda Prada L; Gavrancic T; Cadena Sanabria MO; Dumic I; Bourgeois K; King RL; Yan Y
    Am J Case Rep; 2023 Nov; 24():e941789. PubMed ID: 37957950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nivolumab-induced thyroid dysfunction.
    Tanaka R; Fujisawa Y; Maruyama H; Nakamura Y; Yoshino K; Ohtsuka M; Fujimoto M
    Jpn J Clin Oncol; 2016 Jun; 46(6):575-9. PubMed ID: 27012985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone Marrow Findings of Immune-Mediated Pure Red Cell Aplasia Following Anti-Programmed Cell Death Receptor-1 Therapy: A Report of Two Cases and Review of Literature.
    Le Aye L; Harris JB; Siddiqi I; Hagiya A
    J Hematol; 2019 Jun; 8(2):71-78. PubMed ID: 32300448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Readministration of Nivolumab after Persistent Immune-related Colitis in a Patient with Recurrent Melanoma.
    Fujii Y; Nishikawa Y; Nomura M; Miyamoto S; Uneno Y; Horimatsu T; Muto M
    Intern Med; 2018 Apr; 57(8):1173-1176. PubMed ID: 29269640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in the clinical management of pure red cell aplasia and future prospects].
    Hirokawa M
    Rinsho Ketsueki; 2016 Feb; 57(2):110-6. PubMed ID: 26935627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pure red cell aplasia and pseudothrombocytopenia associated with hepatitis A].
    Tomonari A; Hirai K; Aoki H; Mima N; Kashiwagi S; Masuda K; Shinohara M; Kosaka M
    Rinsho Ketsueki; 1991 Feb; 32(2):147-51. PubMed ID: 1902878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer.
    Godwin JL; Jaggi S; Sirisena I; Sharda P; Rao AD; Mehra R; Veloski C
    J Immunother Cancer; 2017; 5():40. PubMed ID: 28515940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy-associated autoimmune hemolytic anemia.
    Khan U; Ali F; Khurram MS; Zaka A; Hadid T
    J Immunother Cancer; 2017; 5():15. PubMed ID: 28239468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia.
    Diehl LF; Ketchum LH
    Semin Oncol; 1998 Feb; 25(1):80-97. PubMed ID: 9482530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of tacrolimus-related pure red cell aplasia and autoimmune hemolytic anemia with rituximab in a pediatric cardiac transplant patient.
    Abongwa C; Abusin G; El-Sheikh A
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28598573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exacerbation of autoimmune hemolytic anemia associated with pure red cell aplasia after COVID-19: A case report.
    Kimura H; Furukawa M; Shiga Y; Kai T; Yasuda I; Katoh S; Sando E
    J Infect Chemother; 2023 Aug; 29(8):787-791. PubMed ID: 37044274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nivolumab-induced vitiligo in a metastatic melanoma patient: A case report.
    Edmondson LA; Smith LV; Mallik A
    J Oncol Pharm Pract; 2017 Dec; 23(8):629-634. PubMed ID: 27609337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uveitis induced by programmed cell death protein 1 inhibitor therapy with nivolumab in metastatic melanoma patient.
    Kanno H; Ishida K; Yamada W; Nishida T; Takahashi N; Mochizuki K; Mizuno Y; Matsuyama K; Takahashi T; Seishima M
    J Infect Chemother; 2017 Nov; 23(11):774-777. PubMed ID: 28527652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nivolumab: Immunotherapy in Malignant Melanoma.
    Bayless H; Schneider S
    Clin J Oncol Nurs; 2015 Aug; 19(4):430-2. PubMed ID: 26207707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic Epidermal Necrolysis-like Reaction With Severe Satellite Cell Necrosis Associated With Nivolumab in a Patient With Ipilimumab Refractory Metastatic Melanoma.
    Nayar N; Briscoe K; Fernandez Penas P
    J Immunother; 2016 Apr; 39(3):149-52. PubMed ID: 26938948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Features of Nivolumab-Induced Thyroiditis: A Case Series Study.
    Yamauchi I; Sakane Y; Fukuda Y; Fujii T; Taura D; Hirata M; Hirota K; Ueda Y; Kanai Y; Yamashita Y; Kondo E; Sone M; Yasoda A; Inagaki N
    Thyroid; 2017 Jul; 27(7):894-901. PubMed ID: 28537531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Nivolumab in Patients With BRAF V600 Mutant and BRAF Wild-Type Advanced Melanoma: A Pooled Analysis of 4 Clinical Trials.
    Larkin J; Lao CD; Urba WJ; McDermott DF; Horak C; Jiang J; Wolchok JD
    JAMA Oncol; 2015 Jul; 1(4):433-40. PubMed ID: 26181250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.